SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

GSK Q3 Core Earnings Edge Lower as Sales Increase; 2026 Outlook Affirmed

GSK reported Q3 core earnings of 0.546, while sales increased. The company affirmed its 2026 outlook.

GSK
SquawkNews Desk 1 updates Updated Oct 28, 2026, 08:58 AM UTC

Story updates

08:58:58 AM UTC
SquawkNews
Reports Q3 (Sep) earnings of GBP0.55 per share, GBP0.05 better than the FactSet Consensus of GBP0.50

Related stories

Abound Declares H2Si Power in Default of License Agreement Abound Energy says it has declared H2Si Power, Amerada R&D and Robert McKenzie in material default of the H2Si Technology Commercialization license agreement. M impact | EQUITY | Oct 31, 2026, 01:54 AM UTC Freedom Broker Raises Mondelez to Buy From Hold Freedom Broker raised its rating on Mondelez from Hold to Buy. H impact | EQUITY | Oct 31, 2026, 01:48 AM UTC Intel Shares Plunge 29% Intel shares fell 29% in what was described as the company’s worst day in 52 years. H impact | EQUITY | Oct 31, 2026, 01:44 AM UTC Freedom Broker Downgrades Intel to Hold, Cuts Price Target to $90 Freedom Broker lowered its Intel price target to $90 from $100. The revised target implies 36.9% upside from the Oct. 30 close of $65.76. M impact | EQUITY | Oct 31, 2026, 01:36 AM UTC Freedom Broker Upgrades PACCAR to Buy, Cuts Price Target to $120 Freedom Broker raised its rating on PACCAR from Hold to Buy and lowered its price target from $132 to $120. H impact | EQUITY | Oct 31, 2026, 01:30 AM UTC Nasdaq Falls Nearly 3%, on Track for Worst Month Since Trump Trade War Began The Nasdaq fell nearly 3% and was experiencing its worst month since the start of the Trump trade war. M impact | EQUITY | Oct 31, 2026, 12:43 AM UTC